Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: A randomized, double blind, placebo-controlled study

By Medeiros Camila   Carvalhedo de Bruin Pedro   Lopes Lívia   Magalhães Maria   de Lourdes Seabra Maria   Sales de Bruin Veralice  

Journal of Neurology, Vol. 254, Iss. 4, 2007-04 ,pp. : 459-464

Springer Publishing Company

Access to resources Recommend Favorite

A Multicenter, Double-Blind, Placebo-Controlled Trial of the PDE9A Inhibitor, PF-04447943, in Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 5, 2014-06 ,pp. : 413-421

Bentham Science Publishers

Access to resources Recommend Favorite

Quetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind,Placebo-Controlled Study

By  

Current Alzheimer Research, Vol. 4, Iss. 1, 2007-02 ,pp. : 81-93

Bentham Science Publishers

Access to resources Recommend Favorite

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By Collin C.   Ehler E.   Waberzinek G.   Alsindi Z.   Davies P.   Powell K.   Notcutt W.   O'Leary C.   Ratcliffe S.   Nováková I.   Zapletalova O.   Piková J.   Ambler Z.  

Neurological Research, Vol. 32, Iss. 5, 2010-06 ,pp. : 451-459

Maney Publishing

Access to resources Recommend Favorite

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

By Beghi Ettore   Pupillo Elisabetta   Bonito Virginio   Buzzi Paolo   Caponnetto Claudia   Chiò Adriano   Corbo Massimo   Giannini Fabio   Inghilleri Maurizio   Bella Vincenzo La   Logroscino Giancarlo   Lorusso Lorenzo   Lunetta Christian   Mazzini Letizia   Messina Paolo   Mora Gabriele   Perini Michele   Quadrelli Maria Lidia   Silani Vincenzo   Simone Isabella L.   Tremolizzo Lucio  

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 14, Iss. 5-6, 2013-09 ,pp. : 397-405

Informa Healthcare

Access to resources Recommend Favorite